Roman Butler Fullerton & Co’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,277
Closed -$675K 288
2026
Q1
$675K Buy
+15,277
New +$657K 0.19% 132
2025
Q4
Sell
-14,156
Closed -$558K 267
2025
Q3
$558K Buy
+14,156
New +$569K 0.15% 146

Other funds holding EXEL

Roman Butler Fullerton & Co's EXEL Position: Q2 2026 in Review

Roman Butler Fullerton & Co sold out of Exelixis (EXEL) in Q2 2026, closing a stake of 15,277 shares — an estimated $675K sold.

Roman Butler Fullerton & Co first reported a position in EXEL in Q3 2025 and held it in 2 quarters. The position peaked at $675K in Q1 2026. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Roman Butler Fullerton & Co reported no remaining Exelixis position as of Q2 2026 after selling out during the quarter.
  • Roman Butler Fullerton & Co sold 15,277 Exelixis shares in Q2 2026, an estimated $675K.
  • Roman Butler Fullerton & Co first reported a position in Exelixis in Q3 2025 and held it in 2 quarters.
  • Roman Butler Fullerton & Co's Exelixis position peaked at $675K in Q1 2026.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Roman Butler Fullerton & Co's 13F filing for Q2 2026, filed 6 Aug 2026.